Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines
Clinical trial NCT00907387 · COMPLETED
Trial details
- NCT number
- NCT00907387
- Sponsor
- Revance Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-01
- Primary completion
- 2009-10-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.